Casdin Capital
Hedge Fund
Research investment firm focused on innovations in molecular medicine reshaping life sciences and healthcare.
Seed
Early Stage
Growth
Late Stage
Biotech
Healthcare
Life Sciences
Synthetic Biology
- Headquarters
- New York, United States
- Founded
- 2011
- Website
- casdincapital.com
- AUM
- $2.4B
- Portfolio Company
- 1
- Total Investments
- 52
- Last Investment
- Nov 2025
- Geographic Focus
- North America
Investment Thesis
Research investment firm investing in disruptive businesses in life sciences and healthcare — including healthcare, biotechnology, synthetic biology, and life science technology platforms. Focuses on companies at the crossroads of science and investment that are advancing precision medicine, genomics, diagnostics, and molecular-based therapeutics.
Portfolio1
Investment History
Sign up to view investment history
Create a free account to see deal history, investment amounts, and round details.
Create Free Account